Mineralys Therapeutics (MLYS) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.13
-0.97
-0.82
-0.66

Details

Expected EPS
-0.738571
Actual EPS
-0.66
Surprise EPS
0.08
Surprise Percent
+10.64%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.66 per share for Q3 2025.

0 Comments

Share your thoughts